Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for ...
While the financial statements in the Company’s 2025 Annual Report reflect a year focused primarily on corporate restructuring and building the Company’s acquisition platform, management believes the ...
A live webcast of the presentation will be available on the “Investors” page under the “Events” section of the Company’s website at https://ir.lbpharma.us/investors/events/, where a replay of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results